| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.4 | 0.004 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |